This content is from: Direct Tax

ImClone lowers earnings to cover CEO’s tax bill

Biotech company ImClone announced last week that it is delaying the announcement of its financial results and may be forced to restate its earnings from 2001 onwards to cover the unpaid taxes of its former chief executive

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial